CTBP1 and lung carcinoma: In addition to binding of nicotine to nAChRs, that act as the principal sites for its biological action, nicotine signaling has also been shown to activate β-Ars, triggering the production of β-AR ligands, for example, adrenaline and noradrenaline, which contribute to cell proliferation and lung cancer development [7,8].